NCT05489211 2026-03-19Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)AstraZenecaPhase 2 Recruiting454 enrolled
NCT00751205 2014-10-28Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)BayerPhase 2 Completed150 enrolled